BACKGROUND: The aim was to examine health benefits and lifestyle factors after Roux-en-Y gastric bypass (RYGB). METHODS: Patients (n = 165) were investigated 2 years after RYGB in relation to psychopharmaceutical drugs, employment status, type 2 diabetes mellitus (T2DM), hypertension, metabolic syndrome (MetS), body weight, physical activity (PA), and energy intake. RESULTS: Excess weight loss (EWL) was 71.4 ± 20.6 %. Prevalence of T2DM, hypertension, and MetS was reduced (P < 0.001 for all). There were no changes in the use of psychopharmaceutical drugs (20.6 vs. 18.8 %, P = 0.549) or in the proportion of unemployed participants (37.7 vs. 33.3 %, P = 0.189) from pre- to post-surgery. Eighty-three percent achieved EWL ≥ 50 %. These subjects had a lower pre-surgery BMI. We found no differences in the prevalence of hypertension, T2DM, and MetS pre-surgery, but the prevalence was lower after surgery compared with subjects with EWL < 50 %. CONCLUSION: RYGB induced remission of T2DM, hypertension, and MetS 2 years after surgery. The benefit was greatest in the group with EWL ≥ 50 %. Despite excellent weight loss, there was no change in the use of psychopharmaceutical drugs or proportion of unemployed participants.
BACKGROUND: The aim was to examine health benefits and lifestyle factors after Roux-en-Y gastric bypass (RYGB). METHODS:Patients (n = 165) were investigated 2 years after RYGB in relation to psychopharmaceutical drugs, employment status, type 2 diabetes mellitus (T2DM), hypertension, metabolic syndrome (MetS), body weight, physical activity (PA), and energy intake. RESULTS:Excess weight loss (EWL) was 71.4 ± 20.6 %. Prevalence of T2DM, hypertension, and MetS was reduced (P < 0.001 for all). There were no changes in the use of psychopharmaceutical drugs (20.6 vs. 18.8 %, P = 0.549) or in the proportion of unemployed participants (37.7 vs. 33.3 %, P = 0.189) from pre- to post-surgery. Eighty-three percent achieved EWL ≥ 50 %. These subjects had a lower pre-surgery BMI. We found no differences in the prevalence of hypertension, T2DM, and MetS pre-surgery, but the prevalence was lower after surgery compared with subjects with EWL < 50 %. CONCLUSION: RYGB induced remission of T2DM, hypertension, and MetS 2 years after surgery. The benefit was greatest in the group with EWL ≥ 50 %. Despite excellent weight loss, there was no change in the use of psychopharmaceutical drugs or proportion of unemployed participants.
Authors: Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel Journal: N Engl J Med Date: 2004-12-23 Impact factor: 91.245
Authors: Stacy A Brethauer; Ali Aminian; Héctor Romero-Talamás; Esam Batayyah; Jennifer Mackey; Laurence Kennedy; Sangeeta R Kashyap; John P Kirwan; Tomasz Rogula; Matthew Kroh; Bipan Chand; Philip R Schauer Journal: Ann Surg Date: 2013-10 Impact factor: 12.969
Authors: A Laurenius; I Larsson; K J Melanson; A K Lindroos; H Lönroth; I Bosaeus; T Olbers Journal: Eur J Clin Nutr Date: 2013-01-09 Impact factor: 4.016
Authors: Torgeir T Søvik; Erlend T Aasheim; Osama Taha; My Engström; Morten W Fagerland; Sofia Björkman; Jon Kristinsson; Kare I Birkeland; Tom Mala; Torsten Olbers Journal: Ann Intern Med Date: 2011-09-06 Impact factor: 25.391
Authors: K H Pietiläinen; M Korkeila; L H Bogl; K R Westerterp; H Yki-Järvinen; J Kaprio; A Rissanen Journal: Int J Obes (Lond) Date: 2009-12-15 Impact factor: 5.095
Authors: Hira Aftab; Hilde Risstad; Torgeir T Søvik; Tomm Bernklev; Stephen Hewitt; Jon A Kristinsson; Tom Mala Journal: Surg Obes Relat Dis Date: 2013-05-25 Impact factor: 4.734
Authors: Bernard M F M Duvivier; Nicolaas C Schaper; Michelle A Bremers; Glenn van Crombrugge; Paul P C A Menheere; Marleen Kars; Hans H C M Savelberg Journal: PLoS One Date: 2013-02-13 Impact factor: 3.240
Authors: Michael J Courtney; K Mahawar; P Burnell; N Jennings; S Balupuri; N Schroeder; P Small; W Carr Journal: Obes Surg Date: 2018-04 Impact factor: 4.129
Authors: Winda L Ng; Anna Peeters; Ingmar Näslund; Johan Ottosson; Kari Johansson; Claude Marcus; Jonathan E Shaw; Gustaf Bruze; Johan Sundström; Martin Neovius Journal: Obesity (Silver Spring) Date: 2017-06-29 Impact factor: 5.002